DSR - DRUGS & SAVINGS REPORT Trademark

Trademark Overview

On Tuesday, August 17, 2021, a trademark application was filed for DSR - DRUGS & SAVINGS REPORT with the United States Patent and Trademark Office. The USPTO has given the DSR - DRUGS & SAVINGS REPORT trademark a serial number of 90887701. The federal status of this trademark filing is REGISTERED as of Tuesday, February 25, 2025. This trademark is owned by Gemini Health LLC. The DSR - DRUGS & SAVINGS REPORT trademark is filed in the Advertising, Business and Retail Services category with the following description:

Medical cost management; Pharmaceutical cost management services and drug utilization review services
dsr - drugs & savings report

General Information

Serial Number90887701
Word MarkDSR - DRUGS & SAVINGS REPORT
Filing DateTuesday, August 17, 2021
Status700 - REGISTERED
Status DateTuesday, February 25, 2025
Registration Number7706723
Registration DateTuesday, February 25, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 21, 2023

Trademark Statements

Pseudo MarkDSR - DRUGS AND SAVINGS REPORT
Goods and ServicesMedical cost management; Pharmaceutical cost management services and drug utilization review services
NOT AVAILABLE"DRUGS & SAVINGS REPORT"

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code035
First Use Anywhere DateSaturday, December 15, 2018
First Use In Commerce DateSunday, November 1, 2020

Trademark Owner History

Party NameGemini Health LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965
Party NameGemini Health LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965
Party NameGemini Health LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSausalito, CA 94965

Trademark Events

Event DateEvent Description
Friday, June 10, 2022NON-FINAL ACTION E-MAILED
Friday, August 20, 2021NEW APPLICATION ENTERED
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Friday, June 10, 2022NON-FINAL ACTION WRITTEN
Friday, June 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 17, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 6, 2023ASSIGNED TO EXAMINER
Monday, October 16, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 16, 2023SOU EXTENSION 1 FILED
Monday, October 16, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 4, 2024SOU EXTENSION 2 GRANTED
Thursday, April 4, 2024SOU EXTENSION 2 FILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 9, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, October 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 9, 2024SOU EXTENSION 3 FILED
Wednesday, October 9, 2024SOU EXTENSION 3 GRANTED
Wednesday, November 13, 2024USE AMENDMENT FILED
Wednesday, November 13, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, January 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 30, 2025STATEMENT OF USE PROCESSING COMPLETE
Monday, February 3, 2025SU-EXAMINER'S AMENDMENT WRITTEN
Monday, February 3, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, February 3, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, February 3, 2025EXAMINERS AMENDMENT E-MAILED
Monday, February 3, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, February 3, 2025EXAMINER'S AMENDMENT ENTERED
Tuesday, February 25, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, February 25, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

report savings drugs services management cost review utilization pharmaceutical medical drug